Results 191 to 200 of about 692,641 (281)
Abstract This review analyzed 241 scholarly articles published between 2010 and 2025 in information science venues to examine how affect shapes refugees' information behavior during forced migration and to identify additional contextual factors. It identifies seven affective dimensions: anxiety, shame and stigma, grief and loss, frustration, (mis)trust,
Maja Krtalić, Lilach Alon
wiley +1 more source
Any old Tom, Dick, or Harry: The citation impact of author first name genderedness
Abstract This paper examines the relationship between the genderedness of authors' first names and citation distributions in US‐affiliated scholarly production from 2010 to 2019. Merging a first name genderedness table derived from Wikidata with Web of Science publication data, we develop a relative distributional framework that compares first name ...
Maxime Holmberg Sainte‐Marie +1 more
wiley +1 more source
ABSTRACT Among older adults in the general population, medications with anticholinergic (AC) effects are associated with declines in cognitive functioning and with dementia and Alzheimer's disease. Autistic people have high rates of co‐occurring medical conditions and polypharmacy across the lifespan; thus, they may be at particularly high risk of ...
Goldie A. McQuaid +2 more
wiley +1 more source
ABSTRACT Non‐suicidal self‐injury (NSSI) is prevalent among autistic adolescents and adults, yet research on its clinical characteristics, functions, and association with suicidal thoughts and behaviors (STBs) in this population remains limited. This study compared these domains between autistic adolescents and adults with and without recent NSSI.
Safaa Eldeeb +7 more
wiley +1 more source
Mental health risks before the threshold: A longitudinal study of housing cost burden and depressive symptoms in South Korea. [PDF]
Yim T, Kim E, Park J.
europepmc +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Policy interventions to improve health through housing: A scoping review. [PDF]
Buffardi AL, Pascall Jones P, Begault L.
europepmc +1 more source
Sustainability of affordable housing programs in Kenya: A case of Meru and Embu Counties. [PDF]
Gatimbu KK, Nthakanio PN.
europepmc +1 more source

